Mellozzan

Melatonin, the active ingredient in Mellozzan, is a melatonin receptor agonist presented as an oral dosage form for oral use. It helps regulate circadian rhythm and is used to manage insomnia, jet lag, and sleep‑wake rhythm disorders in adults.

GNH USA supplies Mellozzan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mellozzan (melatonin) acts on the melatonin receptor pathway to support normal sleep regulation.

- Insomnia: helps reduce sleep onset latency and improve sleep continuity. - Jet lag: assists in adjusting the internal clock to new time zones, facilitating faster adaptation. - Sleep‑wake rhythm disorders: supports synchronization of disrupted circadian rhythms, improving daytime alertness.

Mellozzan may be associated with a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Drowsiness: feeling of sleepiness during the day. - Headache: mild to moderate head pain. - Nausea: mild stomach upset. - Vivid dreams: unusually intense or memorable dreams.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Mood changes: depression or anxiety worsening. - Hormonal effects: alterations in menstrual cycle or reproductive hormones.

When using Mellozzan, consider the following precautions.

- Assess medical history: review sleep disorders, psychiatric conditions, and hormonal disorders before use. - Avoid driving: do not operate machinery if drowsiness occurs after taking the product. - Concomitant CNS depressants: use caution when combined with alcohol or sedatives. - Pregnancy and lactation: discuss risks with a healthcare professional before use. - Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Mellozzan can interact with other medicines; review the categories below.

Major Interactions (Avoid): - Anticoagulants: may increase bleeding risk. - Immunosuppressants: potential alteration of drug metabolism.

Moderate Interactions (Monitor Closely): - CNS depressants: additive sedative effect. - Oral contraceptives: may reduce efficacy. - Antidepressants (SSRIs): possible serotonin syndrome risk.